Comparative efficacy of two different β-Blockers on 24-Hour blood pressure control

Journal of Clinical Hypertension

Volumn 10, Issue 2, 2008, Pages 112-118

  Sarafidis, Pantelis ^a,b   Bogojevic, Zvezdana ^a   Basta, Emad ^a   Kirstner, Emily ^c   Bakris, George L ^c  

^a RUSH UNIVERSITY   (United States)

^b AHEPA UNIVERSITY HOSPITAL   (Greece)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; METOPROLOL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; CHRONOTHERAPY; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HOSPITALIZATION; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; ATENOLOL; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CHRONOTHERAPY; FEMALE; HUMANS; HYPERTENSION; MALE; METOPROLOL; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 42049104616     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/j.1751-7176.2008.08021.x     Document Type: Article

References (24)

1. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42(6):1206-1252.
2. Parati G., Pomidossi G., Albini F., et al. Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension. J Hypertens. 1987;5(1):93-98.
3. Mancia G., Parati G., Hennig M., et al. Relation between blood pressure variability and carotid artery damage in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis (ELSA). J Hypertens. 2001;19(11):1981-1989.
4. Staessen J.A., Thijs L., Fagard R., et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators. JAMA. 1999;282(6):539-546.
5. Ohkubo T., Hozawa A., Nagai K., et al. Prediction of stroke by ambulatory blood pressure monitoring versus screening blood pressure measurements in a general population: the Ohasama study. J Hypertens. 2000;18(7):847-854.
6. Mancia G., Zanchetti A., Agabiti-Rosei E., et al. Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression of left ventricular hypertrophy. SAMPLE Study Group. Study on Ambulatory Monitoring of Blood Pressure and Lisinopril Evaluation. Circulation. 1997;95(6):1464-1470.
7. Parati G., Ulian L., Santucciu C., et al. Blood pressure variability, cardiovascular risk and antihypertensive treatment. J Hypertens Suppl. 1995;13(4):S27-S34.
8. Muller J.E. Circadian variation in cardiovascular events. Am J Hypertens. 1999;12(2, pt 2):35S-42S.
9. White W.B. The evaluation of antihypertensive therapy using 24-h ambulatory monitoring technology. Blood Press Monit. 2000;5(suppl 2):S13-S17.
10. Sarafidis P.A., Bakris G.L. Are beta blockers passé for the treatment of hypertension? J Clin Hypertens (Greenwich). 2006;8(4):239-240.
11. Freis E.D. Improving treatment effectiveness in hypertension. Arch Intern Med. 1999;159(21):2517-2521.
12. Blomqvist I., Westergren G., Sandberg A., et al. Pharmacokinetics and pharmacodynamics of controlledrelease metoprolol: a comparison with atenolol. Eur J Clin Pharmacol. 1988;33(suppl):S19-S24.
13. Darmansjah I., Wong E., Setiawati A., et al. Pharmacokinetic and pharmacodynamic properties of controlled release (CR/ZOK) metoprolol in healthy Oriental subjects: a comparison with conventional formulations of metoprolol and atenolol. J Clin Pharmacol. 1990;30(2 suppl):S39-S45.
14. Neutel J.M., Schnaper H., Cheung D.G., et al. Antihypertensive effects of beta-blockers administered once daily: 24-hour measurements. Am Heart J. 1990;120(1):166-171.
15. Morgan T.O., Anderson A. Different drug classes have variable effects on blood pressure depending on the time of day. Am J Hypertens. 2003;16(1):46-50.
16. Chen M.F., Yang C.Y., Chen W.J., et al. A double-blind comparison of once-daily metoprolol controlled-release and atenolol in the treatment of Chinese patients with mild to moderate hypertension. Cardiovasc Drugs Ther. 1995;9(3):401-406.
17. Klein G., Berger J., Olsson G., et al. A double-blind comparison of metoprolol CR/ZOK 50 mg and atenolol 50 mg once daily for uncomplicated hypertension. J Clin Pharmacol. 1990;30(2 suppl):S72-S77.
18. Lacourcière Y., Lefebvre J., Provencher P., et al. Comparison of quinapril and atenolol as single drugs or in combination with hydrochlorothiazide in moderate to severe hypertensives, using automated ambulatory monitoring. Br J Clin Pharmacol. 1993;35(2):121-127.
19. Poirier L., Cleroux J., Nadeau A., et al. Effects of nebivolol and atenolol on insulin sensitivity and haemodynamics in hypertensive patients. J Hypertens. 2001;19(8):1429-1435.
20. Aquilante C.L., Terra S.G., Schofield R.S., et al. Sustained restoration of autonomic balance with long- but not shortacting metoprolol in patients with heart failure. J Card Fail. 2006;12(3):171-176.
21. Dahlöf B., Sever P.S., Poulter N.R., et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo- Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet. 2005;366(9489):895-906.
22. Dahlöf B., Devereux R.B., Kjeldsen S.E., et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet. 2002;359(9311):995-1003.
23. Pepine C.J., Handberg E.M., Cooper-DeHoff R.M., et al. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial. JAMA. 2003;290(21):2805-2816.
24. Boggia J., Li Y., Thijs L., et al. Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet. 2007;370(9594):1219-1229.